Trial intelligence / Profile preview

Statins and Lupus

NCT00519363Phase 2Completed

Sponsor
The Center for Rheumatic Disease, Allergy, & Immunology
Start
Sep 2007
Primary completion
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of atorvastatin in systemic lupus erythematosus (SLE), sponsored by The Center for Rheumatic Disease, Allergy, & Immunology. Started Sep 2007; status: completed.

02

Drugs

atorvastatin
03

Conditions

systemic lupus erythematosus (SLE)

Beyond the preview

Go deeper on NCT00519363.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00519363.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call